Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin

by Felley-Bosco Emanuela, Kurtz Stefanie, Hopkins-Donaldson Sally, Marti Thomas M, Belyanskaya Larisa L, Stahel Rolf A
Published 2007-10-01